| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, October 1998, p. 1817-1827, Vol. 75, No. 4
Receptor Biology Laboratory, Department of Physiology and Biophysics, Mayo Foundation, Rochester, Minnesota 55905 USA
We recently showed that at desensitized muscle nicotinic
receptors, epibatidine selects by 300-fold between the two agonist binding sites. To determine whether receptors in the resting, activatible state show similar site selectivity, we studied
epibatidine-induced activation of mouse fetal and adult receptors
expressed in 293 HEK cells. Kinetic analysis of single-channel currents
reveals that (
)-epibatidine binds with 15-fold selectivity to sites
of adult receptors and 75-fold selectivity to sites of fetal receptors. For each receptor subtype, site selectivity arises solely from different rates of epibatidine dissociation from the two sites. To
determine the structural basis for epibatidine selectivity, we
introduced mutations into either the
or the
subunit and measured epibatidine binding and epibatidine-induced single-channel currents. Complexes formed by
and mutant
(K34S+F172I) subunits bind epibatidine with increased affinity compared to 
complexes, whereas the kinetics of
2

(K34S+F172I) receptors
reveal no change in affinity of the low-affinity site, but increased
affinity of the high-affinity site. Conversely, complexes formed by
and mutant
(S36K+I178F) subunits bind epibatidine with decreased affinity compared to 
complexes, whereas the kinetics of
2

(S36K+I178F) and
2

(S36K+I178F) receptors show markedly reduced
sensitivity to epibatidine. The overall data show that epibatidine
activates muscle receptors by binding with high affinity to 
and

sites, but with low affinity to the 
site.
Biophys J, October 1998, p. 1817-1827, Vol. 75, No. 4
© 1998 by the Biophysical Society 0006-3495/98/10/1817/11 $2.00
This article has been cited by other articles:
![]() |
G. Akk, L. S Milescu, and M. Heckmann Activation of heteroliganded mouse muscle nicotinic receptors J. Physiol., April 15, 2005; 564(2): 359 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Pennington, F. Gao, S. M. Sine, and R. J. Prince Structural Basis for Epibatidine Selectivity at Desensitized Nicotinic Receptors Mol. Pharmacol., January 1, 2005; 67(1): 123 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Dahan, M. I. Dibas, E. J. Petersson, V. C. Auyeung, B. Chanda, F. Bezanilla, D. A. Dougherty, and H. A. Lester A fluorophore attached to nicotinic acetylcholine receptor {beta}M2 detects productive binding of agonist to the {alpha}{delta} site PNAS, July 6, 2004; 101(27): 10195 - 10200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Hansen, Z. Radic', T. T. Talley, B. E. Molles, T. Deerinck, I. Tsigelny, and P. Taylor Tryptophan Fluorescence Reveals Conformational Changes in the Acetylcholine Binding Protein J. Biol. Chem., October 25, 2002; 277(44): 41299 - 41302. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Prince, R. A. Pennington, and S. M. Sine Mechanism of Tacrine Block at Adult Human Muscle Nicotinic Acetylcholine Receptors J. Gen. Physiol., August 26, 2002; 120(3): 369 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Prince and S. M. Sine Acetylcholine and Epibatidine Binding to Muscle Acetylcholine Receptors Distinguish between Concerted and Uncoupled Models J. Biol. Chem., July 9, 1999; 274(28): 19623 - 19629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |